MoonLake Immunotherapeutics

MLTX

0 Followers
$38.62 -2.82% -$1.12
Follow
5 August
Upcoming Earnings
 
Market Cap.
 
P/E
Overview Metrics Financials
Loading...

MLTX Fair Price

$83.01
Overvalued by 10.9%
To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

MoonLake Immunotherapeutics is a biotechnology company focused on developing immunotherapies for the treatment of autoimmune diseases and cancer. The company utilizes advanced technology that combines biological molecules and monoclonal antibodies for targeted therapy, focusing on specific immune pathways that are critical for the development of various diseases. MoonLake specializes in developing drugs for conditions such as psoriasis, cancer, and other autoimmune disorders, aiming to provide new and effective therapeutic options for patients with these serious diseases.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade